Bile Duct Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Bile Duct Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma [Phase 2]
Phase 2 trial evaluating Disitamab Vedotin in combination with Cadonilimab for HER2-mutant non-resectable biliary tract adenocarcinoma, curr…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma [Phase 2]
Phase 2 trial evaluating surufatinib plus cadonilimab in unresectable or metastatic bile duct adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations [Phase 2]
Phase 2 trial investigating olaparib for metastatic biliary tract cancer with aberrant DNA repair gene mutations.